Literature Review: Moving the Druggable Needle
The Use of an mRNA Display Technology and Affinity-Based Selection Is Used to Find Inhibitors to an Enzyme of Interest
To Surge or Not to Surge?
Experts Discuss Inclusion of a Surge Tank in an End-to-End Continuous Biomanufacturing Train
New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
The views, opinions, findings, conclusions, and recommendations set forth in any article in Genetic Engineering & Biotechnology News (GEN) are solely those of the authors of those articles and do not necessarily reflect the views, policy, or position of GEN, its Publisher, or its editorial staff and should not be attributed to any of them.
All advertisements are subject to review by the Publisher. The acceptance of advertisements does not constitute an endorsement of the product or service advertised.
The entire website is the property of Genetic Engineering & Biotechnology News. All rights reserved. Any unauthorized reproduction or redistribution of the website is strictly prohibited. You must obtain permission before using trademarks of Genetic Engineering & Biotechnology News. Any other trademarks or logos appearing on our website are the property of their respective owners.
Hyperlinks to Third Party Sites
This website may contain hyperlinks to third-party websites. Such hyperlinks are provided for reference by and convenience of website users. Genetic Engineering & Biotechnology News is not responsible for the content on third-party websites. Our inclusion of hyperlinks our website does not imply endorsement of the linked website or the company that maintains it.